Prevalence of VZV Reactivation and Effectiveness of Vaccination with Recombinant Adjuvanted Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Recipients—A Single-Center Analysis
Herpes zoster occurred mainly in the late period after allo-HSCT after completion of acyclovir prophylaxis in over 30% of recipients. The preliminary results indicate that RZV vaccination after allo-HSCT was safe and more than 80% effective at preventing HZ, but some vaccinated individuals did experience HZ.
Authors
- Grzegorz Władysław Basak (ORCID: https://orcid.org/0000-0003-3858-8180)
- Ewa Karakulska‐Prystupiuk (ORCID: https://orcid.org/0000-0002-0201-5041)
- Magdalena Feliksbrot‐Bratosiewicz
- Agnieszka Tomaszewska (ORCID: https://orcid.org/0000-0002-3211-5713)
- W Wiktor-Jędrzejczak (ORCID: https://orcid.org/0000-0002-6813-3331)
- Maria Król
Institutions
- Medical University of Warsaw (PL)
Publication Details
- Journal
- Infectious Disease Reports
- Published
- 2025-05-02
- DOI
- https://doi.org/10.3390/idr17030048
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00